Somnair Selected as Finalist for 2025 SXSW PITCH

​

SOMNAIR SELECTED AS FINALIST FOR 2025 SXSW PITCH 

SOMNAIR to showcase their revolutionary non-invasive neurostimulation technology for the treatment of obstructive sleep apnea in the HealthTech, MedTech, BioTech & Accessibility category 

 

Baltimore, MD — January 24th, 2025 — Somnair, a medical device company developing the first entirely non-invasive neurostimulation technology for the treatment of obstructive sleep apnea  was selected as a finalist in the HealthTech, MedTech, BioTech & Accessibility category for the 17th annual SXSW Pitch. 

 

SXSW Pitch, presented by KPMG, is the marquee event of South by Southwest® (SXSW®) Conference & Festivals (March 7 - 15, 2025), where leading startups from around the world showcase some of the most impressive technology innovations to a panel of hand-picked judges and a live audience. Out of the 589 companies that applied to present at SXSW Pitch 2025, Somnair was selected among the 45 finalists, spanning nine separate categories.

 

The two-day event will be held the first weekend of SXSW Conference & Festivals, Saturday, March 8 and Sunday, March 9, at the Downtown Hilton Austin. The event will then culminate with the 2025 SXSW Pitch Awards Ceremony on Sunday evening, March 9, where winning startups from each category and a Best in Show winner will be announced and honored in Salon H on the sixth floor of the Hilton Hotel. 

 

SXSW Pitch will feature finalists across the following nine categories: AgTech & Food, Enterprise, Smart Data, FinTech & Future of Work, Entertainment, Media, Sports & Content, Robotics, Web3, Voice & Extended Reality, HealthTech, MedTech, BioTech & Accessibility, Innovative World Tech, Security, GovTech & Space, Smart Cities, Transportation & Sustainability, and Student Startups. 

 

Somnair will present among four other companies in the HealthTech, MedTech, BioTech & Accessibility category on March 8th, 2025. 

 

“At Somnair, we are thrilled for the opportunity to share our vision for a world without uncomfortable and ineffective treatments for obstructive sleep apnea, a disease that afflicts 54 million Americans and 1 billion people worldwide. Our novel, proprietary non-invasive neurostimulation device will finally bring disease relief to so many who struggle with this debilitating disease ”, Dr Anders Sideris, CEO & Co-Founder.

 

SXSW Pitch has been dedicated to championing the startup community since its establishment in 2009. 

 

Since its inception, SXSW Pitch has strived to support the early-stage venture ecosystem, providing the resources and exposure necessary to help start-ups not only succeed but thrive,” said SXSW Pitch Event Producer Chris Valentine. “The 45 companies selected as finalists for the 2025 program serve as the next ambassadors of innovation across the globe. We are looking forward to having these startups take the stage in March to present their technologies to our panel of expert judges.”
 

For more information about SXSW Pitch and to view the complete list of finalists, visit: https://www.sxsw.com/pitch.